Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 9/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2135813 | 1.00 | STAT3 (0.52) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29425958 | 0.92 | STAT3 (0.54) | STAT3MAPTMEN1KMT2APOLB | |
| Secologanin SCHEMBL431171 | 0.89 | STAT3 (0.55) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL28663748 | 0.82 | STAT3 (0.55) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29425822 | 0.81 | POLB (0.47) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL31006406 | 0.78 | STAT3 (0.55) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29629350 | 0.78 | POLB (0.49) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29391273 | 0.78 | POLB (0.49) | STAT3MAPTMEN1KMT2APOLB | |
| SCHEMBL29425794 | 0.75 | STAT3 (0.57) | STAT3MAPTMEN1KMT2APOLB | |
| Scandoside SCHEMBL307654 | 0.72 | L3MBTL1 (0.61) | STAT3MAPTMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024168348-A1 | PRODUCTION OF MONOTERPENE INDOLE ALKALOID COMPOUNDS IN A HETEROLOGOUS HOST | TRYPTAGENIX, INC. (US) | 2024-08-15 | — | — | WO | claimed |
| CN-115792070-A | Method for measuring content of iridoid component in honeysuckle oral liquid | 真奥金银花药业有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-20260144839-A1 | METHOD FOR ENHANCING ACTIVITY OF MITOCHONDRIA | TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD. (TW) | 2026-05-28 | — | — | US | disclosed |
| EP-4702037-A1 | METHOD OF PRODUCING IRIDOIDS | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| US-20250017997-A1 | USE OF EXTRACT IN MANUFACTURING A PHARMACEUTICAL OR NON-PHARMACEUTICAL COMPOSITION FOR ENHANCING THE ACTIVITY OF MITOCHONDRIA | TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD. (TW) | 2025-01-16 | — | — | US | disclosed |
| CN-119258114-A | Application of extract in preparation of pharmaceutical or non-pharmaceutical composition for improving mitochondrial activity | 台湾粒线体应用技术股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| WO-2024224085-A1 | METHOD OF PRODUCING IRIDOIDS | Nicoventures Trading Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| WO-2024168348-A1 | PRODUCTION OF MONOTERPENE INDOLE ALKALOID COMPOUNDS IN A HETEROLOGOUS HOST | TRYPTAGENIX, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| WO-2024144265-A1 | COMPOSITION FOR PREVENTING OR TREATING FINE DUST-INDUCED RESPIRATORY DISEASES CONTAINING LONICERA JAPONICA EXTRACT AS ACTIVE INGREDIENT | 경상국립대학교산학협력단 | 2024-07-04 | — | — | WO | disclosed |
| CN-117898059-A | Soil continuous cropping obstacle treatment method and application | 江西农业大学 | 2024-04-19 | — | — | CN | disclosed |
| CN-115950972-A | Ultra-high performance liquid phase-mass spectrometry detection method for scourge-clearing lung-protecting particles | 陕西省中医药研究院 | 2023-04-11 | — | — | CN | disclosed |
| CN-115792070-A | Method for measuring content of iridoid component in honeysuckle oral liquid | 真奥金银花药业有限公司 | 2023-03-14 | — | — | CN | disclosed |
| US-20150037870-A1 | ENZYME CATALYSTS FOR DIELS-ALDER REACTIONS | UNIVERSITY OF WASHINGTON (US) | 2015-02-05 | — | — | US | disclosed |
| US-20120100594-A1 | ENZYME CATALYSTS FOR DIELS-ALDER REACTIONS | UNIVERSITY OF WASHINGTON (US) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144839-A1 | METHOD FOR ENHANCING ACTIVITY OF MITOCHONDRIA | CS, PC, FIS1 | STAT3 264/4885MAPT 3781/4885MEN1 4769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.